<DOC>
	<DOCNO>NCT00163137</DOCNO>
	<brief_summary>To compare effect 2 year lasofoxifene treatment 2 year raloxifene 60 mg/day use 2 year placebo use bone mineral density ( BMD ) lumbar spine .</brief_summary>
	<brief_title>Comparison Raloxifene Lasofoxifene - A Randomized , Blinded Study These Drugs Placebo Bone Loss</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Postmenopausal woman low bone density ( osteopenia ) screen lab , pelvic ultrasound , mammogram without significant finding Presence metabolic bone disease , fracture , blood clot , recent cancer . Any use selective estrogen receptor modulators , investigational drug , recent use osteoporosis treatment , certain hormone , medication blood clot seizure .</criteria>
	<gender>Female</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>